Document is current
Any future updates will be listed below
-
Authors
Miura, Gen https://orcid.org/0000-0001-6288-8840
Fujiwara, Tadami
Ozawa, Yoshihito
Shiko, Yuki
Kawasaki, Yohei
Nizawa, Tomohiro
Tatsumi, Tomoaki
Kurimoto, Takuji
Mori, Sotaro
Nakamura, Makoto
Hanaoka, Hideki
Baba, Takayuki
Yamamoto, Shuichi
-
Funding
Funding for this research was provided by:
Chiba University (9A01V810b2019)
- License Information
-
More Information
Article History
Received: 13 June 2023
Accepted: 12 September 2023
First Online: 25 October 2023
Declarations
:
: The IRB of all three institutions has approved the trial. This trial will be conducted in accordance with the Ordinance on the Standards for the Implementation of Clinical Trials (GCP Ordinance) and the principles of the Declaration of Helsinki of the World Medical Association. All participants will receive adequate information about the purpose, nature, benefits, and possible risks of this trial, and alternative therapeutic choices by investigator, using an informed consent form approved by the IRB at the Chiba University Hospital and two other institutions. Participant-signed informed consent forms were required to be enrolled in this trial. This trial was registered in the UMIN Clinical Trials Registry (UMIN000036220) on 15/03/2019. Written informed consent was obtained from the patient for participation of this case report. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
: Written informed consent was obtained from the patient for publication of this case report and any accompanying images.
: The authors declare no competing interests. Mayo Co., Ltd. had no role in the study design, data collection, data analysis, data interpretation, or writing of the protocol.
